AGMB Aligns With FDA
Agomab Therapeutics aligns with FDA on design of Phase 2b NOV-ERA study with Ontunisertib
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.